Capricor Therapeutics, Inc. (CAPR)
8.37
+0.07
(+0.84%)
USD |
NASDAQ |
Sep 11, 16:00
8.40
+0.03
(+0.36%)
After-Hours: 20:00
Capricor Therapeutics Market Cap : 486.37M for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 486.37M |
| September 10, 2026 | 482.30M |
| September 09, 2026 | 502.06M |
| September 08, 2026 | 526.47M |
| September 04, 2026 | 546.22M |
| September 03, 2026 | 539.25M |
| September 02, 2026 | 574.70M |
| September 01, 2026 | 581.67M |
| August 31, 2026 | 575.86M |
| August 28, 2026 | 557.27M |
| August 27, 2026 | 584.58M |
| August 26, 2026 | 543.90M |
| August 25, 2026 | 481.72M |
| August 24, 2026 | 395.14M |
| August 21, 2026 | 365.51M |
| August 20, 2026 | 397.18M |
| August 19, 2026 | 463.71M |
| August 18, 2026 | 411.41M |
| August 17, 2026 | 432.91M |
| August 14, 2026 | 386.42M |
| August 13, 2026 | 244.64M |
| August 12, 2026 | 243.48M |
| August 11, 2026 | 228.37M |
| August 10, 2026 | 223.72M |
| August 07, 2026 | 235.85M |
| Date | Value |
|---|---|
| August 06, 2026 | 241.04M |
| August 05, 2026 | 226.62M |
| August 04, 2026 | 240.46M |
| August 03, 2026 | 242.19M |
| July 31, 2026 | 222.01M |
| July 30, 2026 | 241.62M |
| July 29, 2026 | 378.86M |
| July 28, 2026 | 378.86M |
| July 27, 2026 | 403.36M |
| July 24, 2026 | 1.136B |
| July 23, 2026 | 1.143B |
| July 22, 2026 | 1.090B |
| July 21, 2026 | 1.141B |
| July 20, 2026 | 1.124B |
| July 17, 2026 | 1.121B |
| July 16, 2026 | 1.103B |
| July 15, 2026 | 1.173B |
| July 14, 2026 | 1.193B |
| July 13, 2026 | 1.188B |
| July 10, 2026 | 1.240B |
| July 09, 2026 | 1.297B |
| July 08, 2026 | 1.283B |
| July 07, 2026 | 1.281B |
| July 06, 2026 | 1.293B |
| July 02, 2026 | 1.338B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| REGENXBIO, Inc. | 462.02M |
| Cytokinetics, Inc. | 10.24B |
| Emergent BioSolutions, Inc. | 319.60M |
| Rigel Pharmaceuticals, Inc. | 881.21M |
| United Therapeutics Corp. | 21.22B |
Market Cap Related Metrics
| PEG Ratio | -0.0694 |
| Price to Book Value | 1.975 |
| Price | 8.37 |
| Earnings Yield | -29.26% |
| PEGY Ratio | -0.0694 |